Memory Buttons in Combination with Mobile Application-Induced Objective and Subjective Effects in Patients with Atopic Dermatitis

Kristina M Joergensen; Christian Vestergaard; Morten S Joergensen; Aleksander Eiken; Martin Malmstedt-Miller; Anders N Ø Schultz; Mette Deleuran; John R Zibert

doi:10.1155/2020/8915893

Memory Buttons in Combination with Mobile Application-Induced Objective and Subjective Effects in Patients with Atopic Dermatitis

Dermatol Res Pract. 2020 Feb 13:2020:8915893. doi: 10.1155/2020/8915893. eCollection 2020.

Authors

Kristina M Joergensen¹, Christian Vestergaard², Morten S Joergensen¹, Aleksander Eiken¹, Martin Malmstedt-Miller^{1

3}, Anders N Ø Schultz¹, Mette Deleuran², John R Zibert¹

Affiliations

¹ LEO Innovation Lab, Copenhagen, Denmark.
² Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
³ Abdominal Center, Department of General Surgery, Herlev Hospital, Copenhagen, Denmark.

Abstract

Background: Atopic dermatitis (AD) is a chronic skin condition where nonadherence often results in lack of disease control.

Objective: We wanted to determine whether the combination of an electronic memory button and a supportive application (app) would affect the Quality of Life and subjective and objective severity measures among AD patients over one month following the patient's normal schedules of treatment.

Methods: A randomized, investigator-blinded, prospective observational feasibility study for one month where patients diagnosed with AD were randomized based on POEM severity score and divided into 3 groups. The 3 groups were (1) the control group with two consultations, (2) in addition to group 1, patients also received electronic memory buttons to click every time they used their topical products, and (3) in addition to group 2, patients also received an app to track their treatment schedules. At both consultations, patients were evaluated using SCORAD, EASI, POEM, and DLQI.

Results: 96 patients were enrolled and randomized, of which 83 patients completed the study. EASI and SCORAD scores were lower in all groups at 2^nd consultation (p < 0.05); however, these were highly significant for group 3 (p < 0.05); however, these were highly significant for group 3 (p < 0.05); however, these were highly significant for group 3 (p < 0.05); however, these were highly significant for group 3 (.

Conclusion: A reduction in severity following objective assessments of the AD was observed for all groups and was highly significant for patients offered a memory button and the corresponding app. Furthermore, patients reported a significant subjective beneficial effect if they used the memory button and app. This indicates that digital solutions may have a benefit in clinical practice and may reduce nonadherence and increase the wellbeing of the patients.